|RFx ID :||20329816|
|Tender Name :||Optimise Methyl bromide Application|
|Reference # :||O - 405757|
|Open Date :||Thursday, 25 October 2018 1:00 PM (Pacific/Auckland UTC+13:00)|
|Close Date :||Friday, 23 November 2018 2:00 PM (Pacific/Auckland UTC+13:00)|
|Tender Type :||Request for Proposals (RFP)|
|Tender Coverage :||Sole Agency [?]|
|Required Pre-qualifications :||None|
|Alternate Physical Delivery Address :|
|Alternate Physical Fax Number :|
New Zealand is reliant on methyl bromide (MeBr) to meet other countries Importing-Country Phytosanitary Requirements (ICPR), and to provide border protection around goods coming into NZ. However, there are domestic (EPA 2010) moves to reduce the amount of MeBr used and released. It is widely accepted that there is currently no direct replacement for MeBr, therefore, other ways to minimise MeBr use such as method improvements during application need to be explored.
This work aims to develop baseline data to determine whether changes in MeBr application methodology can reduce the total minimum volume of MeBr used in treatments while still ensuring the required efficacy of the treatment (the end point concentration of MeBr is reached).
MPI is looking for credible providers who have the capability, experience and infrastructure to deliver our requirements, using expert knowledge of MeBr application along with design of statistically robust trials. Suppliers need to have a good track record of managing and implementing related programmes and developing effective networks and strong relationships with key contacts and third parties.
The services required exclude research into the efficacy of MeBr treatment methods or work to develop alternative treatments to MeBr.
This is an exciting opportunity for a researcher to provide the evidence to support method changes in the application of MeBr. The outcomes of the work will help MPI continue to provide border protection yet also meet domestic obligations to look for opportunities to reduce the amount of MeBr used.